OUR LATEST NEWS

Guadalupe Hayes-Mota, CEO and Founder of Healr Solutions, has been honored as a PharmaVoice 100 winner.

Healr Solutions is excited to announce its participation in the prestigious Frontiers of Engineering Symposium 2023, hosted by the University of Colorado Boulder from September 10-13. Organized by the National Academy of Engineering (NAE), the symposium will see 100 of the most promising early-career engineers from diverse fields converging to share and discuss the latest advancements in engineering.

The unprecedented power of artificial intelligence (AI) is transforming the life sciences industry, opening doors to groundbreaking drug discoveries, innovative treatments and the promise of personalized medicine. As we harness AI's potential, addressing the ethical challenges that arise is imperative. This article outlines a new, robust ethical framework to ensure that AI serves humanity's best interests in life sciences while mitigating potential risks.

Below, 15 Forbes Business Council members share effective strategies that leaders can use to identify operational inefficiencies in their organization and streamline processes to improve overall performance. By implementing these strategies, you can optimize your organization's operations and unlock its full potential.

With the increasing amount of available data, AI and machine learning have emerged as crucial tools for biopharmaceutical companies looking to remain competitive in the market. These tools are helping researchers speed up drug discovery, improve the clinical trial design and further personalize patient treatment.

Here are five areas where I see AI and machine learning changing the biopharmaceutical industry.

The demand for Adderall has surged, with U.S. prescriptions rocketing to 41.4 million in 2021 — a 10.4% increase from 2020, according to IQVIA, a life sciences industry analytics provider. According to the Food and Drug Administration, the spike in demand, coupled with “intermittent manufacturing delays,” have created a national shortage. In an August 2022 survey, almost two-thirds of respondents said they were having trouble securing their Adderall.

Having been unable to obtain access to treatment for haemophilia as a child, Guadalupe Hayes-Mota was determined from a young age that he would dedicate his life to finding a solution. His business, Healr Solutions, is committed to improving biopharmaceutical supply chains in a bid to increase access to life-saving treatments for all

Leaders preparing for work of the future often focus on data and technology, which are already fueling artificial intelligence and algorithms that are transforming the workplace. But human workers shouldn’t get lost in the shuffle. Savvy managers are arming employees with the skills they need to integrate these new technologies into existing workflows.

Guadalupe Hayes-Mota was just 12 years old when he almost died. And although that’s a young age to decide what you want to do for the rest of your life, that experience set the course for Hayes-Mota’s career mission. Born with a rare form of hemophilia in a small town in Mexico, where the availability of medications was a constant challenge, Hayes-Mota knows personally how supply chain issues can impact a patient’s life. As a child, he and his family would take an eight-hour bus ride to his hematologist, and often the medication he needed would not be available once he got there.